drugset / Trial / NCT00961649

Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination

NCT00961649

Phase 2 Terminated 195 enrolled Alcon Research
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study was to compare the safety and intraocular pressure (IOP)-lowering efficacy of a new fixed combination of brinzolamide/brimonidine (Brinz/Brim) to: * its individual components (Brinz and Brim), and * the concomitant administration of Brinz and Brim (Brinz+Brim).

Timeline

Start
2009-10
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brimonidine Small molecule 0.2 % Other
Comparator Brinzolamide Small molecule 1 % Other
Subject brinzolamide/brimonidine Unknown 0.2 % Other
Subject brinzolamide/brimonidine Unknown 1 % Other